These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31202896)

  • 1. Novel insights into the chemistry of an old medicine: A general degradative pathway for penicillins from a piperacillin/tazobactam stability study.
    Viola A; Ferrazzano L; Martelli G; Cerisoli L; Ricci A; Tolomelli A; Cabri W
    Eur J Pharm Sci; 2019 Aug; 136():104957. PubMed ID: 31202896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physical compatibility of vancomycin and piperacillin sodium-tazobactam at concentrations typically used during prolonged infusions.
    Leung E; Venkatesan N; Ly SC; Scheetz MH
    Am J Health Syst Pharm; 2013 Jul; 70(13):1163-6. PubMed ID: 23784164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of piperacillin sodium-tazobactam sodium in peritoneal dialysis solutions.
    Park TW; Le-Bui LP; Chung KC; Rho JP; Gill MA
    Am J Health Syst Pharm; 1995 Sep; 52(18):2022-4. PubMed ID: 8528873
    [No Abstract]   [Full Text] [Related]  

  • 4. Piperacillin-tazobactam: a beta-lactam/beta-lactamase inhibitor combination.
    Gin A; Dilay L; Karlowsky JA; Walkty A; Rubinstein E; Zhanel GG
    Expert Rev Anti Infect Ther; 2007 Jun; 5(3):365-83. PubMed ID: 17547502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Acute Kidney Injury With Concomitant Vancomycin and Piperacillin/Tazobactam Treatment Among Hospitalized Children.
    Downes KJ; Cowden C; Laskin BL; Huang YS; Gong W; Bryan M; Fisher BT; Goldstein SL; Zaoutis TE
    JAMA Pediatr; 2017 Dec; 171(12):e173219. PubMed ID: 28973124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability Studies of Antipyocyanic Beta-Lactam Antibiotics Used in Continuous Infusion.
    Curti C; Souab HK; Lamy E; Mathias F; Bornet C; Guinard B; Fersing C; Primas N; Albanèse J; Vanelle P
    Pharmazie; 2019 Jun; 74(6):357-362. PubMed ID: 31138374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visual and absorbance analyses of admixtures containing vancomycin and piperacillin-tazobactam at commonly used concentrations.
    O'Donnell JN; Venkatesan N; Manek M; Rhodes NJ; Scheetz MH
    Am J Health Syst Pharm; 2016 Feb; 73(4):241-6. PubMed ID: 26843502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Piperacillin/tazobactam: an updated review of its use in the treatment of bacterial infections.
    Perry CM; Markham A
    Drugs; 1999 May; 57(5):805-43. PubMed ID: 10353303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Piperacillin/tazobactam in the treatment of polymicrobial infections.
    Gorbach SL
    Intensive Care Med; 1994 Jul; 20 Suppl 3():S27-34. PubMed ID: 7962986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The chemistry, pharmacokinetics and tissue distribution of piperacillin/tazobactam.
    Sörgel F; Kinzig M
    J Antimicrob Chemother; 1993 Jan; 31 Suppl A():39-60. PubMed ID: 8383655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Piperacillin/tazobactam versus imipenem: a double-blind, randomized formulary feasibility study at a major teaching hospital.
    Marra F; Reynolds R; Stiver G; Bryce E; Sleigh K; Frighetto L; MacDougall C; Jewesson P
    Diagn Microbiol Infect Dis; 1998 Jun; 31(2):355-68. PubMed ID: 9635910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Piperacillin/tazobactam plus tobramycin versus ceftazidime plus tobramycin as empiric therapy for fever in severely neutropenic patients.
    Marie JP; Marjanovic Z; Vekhoff A; Bouvet A; Chast F; Levy V; Baudard M; Legrand O; Rio B; Delmer A; Zittoun R
    Support Care Cancer; 1999 Mar; 7(2):89-94. PubMed ID: 10089089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-performance liquid chromatographic determination of tazobactam and piperacillin in human plasma and urine.
    Augey V; Grosse PY; Albert G; Audran M; Bressolle F
    J Chromatogr B Biomed Appl; 1996 Jun; 682(1):125-36. PubMed ID: 8832433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of piperacillin sodium in the presence of tazobactam sodium in 5% dextrose and normal saline injections.
    Mathew M; Das Gupta V; Bethea C
    J Clin Pharm Ther; 1994 Dec; 19(6):397-9. PubMed ID: 7876373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of galactomannan antigenemia in patients receiving piperacillin-tazobactam and correlations between in vitro, in vivo, and clinical properties of the drug-antigen interaction.
    Walsh TJ; Shoham S; Petraitiene R; Sein T; Schaufele R; Kelaher A; Murray H; Mya-San C; Bacher J; Petraitis V
    J Clin Microbiol; 2004 Oct; 42(10):4744-8. PubMed ID: 15472335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Piperacillin/tazobactam: a new beta-lactam/beta-lactamase inhibitor combination.
    Schoonover LL; Occhipinti DJ; Rodvold KA; Danziger LH
    Ann Pharmacother; 1995 May; 29(5):501-14. PubMed ID: 7655135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of experimental pneumonia in rats caused by a PER-1 extended-spectrum beta-lactamase-producing strain of Pseudomonas aeruginosa.
    Mimoz O; Elhelali N; Léotard S; Jacolot A; Laurent F; Samii K; Petitjean O; Nordmann P
    J Antimicrob Chemother; 1999 Jul; 44(1):91-7. PubMed ID: 10459815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical use of beta-lactamase inhibitors in combination with extended-spectrum penicillins.
    Jones RN
    Am J Health Syst Pharm; 1995 Mar; 52(6 Suppl 2):S29-33. PubMed ID: 7606587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of piperacillin/tazobactam and other broad-spectrum antibiotics against bacteria from hospitalised patients in the British Isles.
    Livermore DM; Mushtaq S; James D; Potz N; Walker RA; Charlett A; Warburton F; Johnson AP; Warner M; Henwood CJ
    Int J Antimicrob Agents; 2003 Jul; 22(1):14-27. PubMed ID: 12842324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do formulation differences between the reference listed drug and generic piperacillin-tazobactam impact reconstitution?
    Zheng H; Truong J; Carroll F; Pai MP
    Antimicrob Agents Chemother; 2015 Mar; 59(3):1767-9. PubMed ID: 25512410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.